How to Credent Connect N Care IPO Allotment Status

Credent Connect N Care Limited is a healthcare services and logistics company providing integrated logistics, workforce solutions and technology-enabled support to diagnostic laboratories, in-vitro diagnostic (IVD) companies, pharmaceutical companies, clinics and other healthcare institutions across India.  

The company commenced operations in 2015 and has expanded its offerings across home sample collection, phlebotomy services, healthcare logistics, manpower deployment and operations and supply-chain services. Its logistics operations include the movement of temperature-sensitive and turnaround-time-critical diagnostic samples and healthcare products.  

Credent Connect also operates C3 Wellness, which provides corporate health camps, vaccination programmes and diagnostic services, and C3 Post, a courier aggregation platform supporting bulk, pan-India and cold-chain logistics.  

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Credent Connect N Care IPO is a book-built SME issue comprising a fresh issue of 49.68 lakh equity shares. The shares are proposed to be listed on the NSE Emerge platform.  

The IPO opened for subscription on August 13, 2026 and closed on August 17, 2026, based on the bidding data provided. Ahead of the public issue, Credent Connect N Care raised approximately ₹26.53 crore from 10 anchor investors.  

Hem Securities Limited is the book-running lead manager to the issue, while KFin Technologies Limited is the registrar.  

Registrar: Kfin Technologies Ltd

NSE: NSE IPO Allotment Status Page

Credent Connect N Care IPO Subscription Status 

Credent Connect N Care IPO was subscribed 153.13 times on August 17, 2026, based on the final subscription data provided. The issue witnessed strong demand across all investor categories, with Non-Institutional Investors recording the highest subscription.

The NII category recorded the strongest demand, reaching 216.97 times subscription. 

Individual Investors subscribed 138.85 times, indicating substantial participation from individual applicants. 

Overall subscription increased sharply from 12.14 times on Day 2 to 153.13 times on Day 3, reflecting a significant surge in bidding during the final day of the offer. 

Credent Connect N Care IPO Share Price and Investment Details 

Credent Connect N Care IPO is a book-built SME issue proposed for listing on NSE Emerge. The issue comprises a fresh issue of 49.68 lakh equity shares, with no offer-for-sale component disclosed in the IPO information reviewed.  

The company also raised ₹26.53 crore from 10 anchor investors before opening the IPO to public investors. The anchor book included participation from institutional investors including Abakkus Asset Management.  

Investor demand during the public offer was substantial. Based on the final data provided, the issue was subscribed 153.13 times overall, with NII demand at 216.97 times, Individual Investors at 138.85 times and QIBs at 130.40 times. 

Given the level of oversubscription, competition for allotment is high across investor categories. Listing performance will ultimately depend on prevailing SME market conditions and investor demand when the shares begin trading. 

Utilisation of IPO Proceeds 

Credent Connect N Care proposes to utilise the fresh issue proceeds for several business requirements. These include investment in its wholly owned subsidiary, Credent Healthcare Private Limited, towards working capital requirements and the purchase of machinery.  

The company also intends to deploy funds towards its own working capital requirements, repayment or prepayment of certain borrowings and general corporate purposes.  

Available IPO disclosures indicate approximately ₹26.30 crore is proposed for the company's working capital requirements, while around ₹17.89 crore is earmarked for the working capital requirements of Credent Healthcare Private Limited. Around ₹4.12 crore is proposed for repayment or prepayment of borrowings.  

Business Overview 

Credent Connect N Care operates within India's healthcare ecosystem but follows a differentiated model centred on the pre-analytical and operational side of diagnostics. Rather than operating only as a conventional diagnostic laboratory, the company provides logistics, sample collection, workforce and technology services that help healthcare organisations manage their operations.  

Its offerings include home sample collection through trained phlebotomists, stationed phlebotomy teams at hospitals and laboratories, deployment of laboratory technicians and paramedical staff, and specialised intra-state and inter-state logistics for healthcare products and diagnostic samples.  

As of September 30, 2025, the company operated a fleet of 94 commercial vehicles for sample transportation and related logistics activities. It was headquartered in Ashok Vihar, Delhi, with two warehouses and four branch offices, including locations in Mumbai, Pune, Chennai and Varanasi.  

The company's total income increased from approximately ₹59.93 crore in FY23 to ₹76.02 crore in FY24 and ₹78.24 crore in FY25. Profit after tax, however, declined from approximately ₹2.70 crore in FY23 to ₹2.66 crore in FY24 and ₹2.25 crore in FY25.  

Key strengths include its integrated healthcare logistics model, presence across multiple healthcare service verticals, temperature-controlled sample transportation capabilities, technology-enabled operations and established relationships with diagnostic and healthcare institutions. 

Investors should also consider risks associated with dependence on healthcare-sector clients, relatively modest profitability, working-capital requirements, execution of time-sensitive healthcare logistics, dependence on trained field personnel, regulatory requirements and competition from other healthcare logistics and diagnostic service providers.